Workflow
Fuller(FUL) - 2025 Q1 - Quarterly Report

Revenue Performance - Net revenue for Q1 2025 was 788.7million,adecreaseof2.7788.7 million, a decrease of 2.7% compared to 810.4 million in Q1 2024[101]. - Organic revenue growth increased by 1.9% in Q1 2025, driven by a 4.2% increase in Hygiene, Health and Consumable Adhesives and a 2.2% increase in Building Adhesive Solutions[101]. - The Engineering Adhesives segment reported net revenue of 236.8millioninQ12025,a4.0236.8 million in Q1 2025, a 4.0% increase from 226.0 million in Q1 2024[119]. - Net revenue for the Hygiene, Health and Consumable Adhesives segment was flat at 0.0millioninQ12025comparedtoQ12024,withorganicgrowthof4.20.0 million in Q1 2025 compared to Q1 2024, with organic growth of 4.2% offset by a negative currency effect of (5.0)%[122]. - Engineering Adheses net revenue increased by 4.7% to 236.8 million in Q1 2025, driven by an 8.7% contribution from M&A, despite a decline in organic growth of (1.9)%[124]. - Building Adhesive Solutions reported a net revenue increase of 2.2% to 183.7millioninQ12025,withorganicgrowthof2.2183.7 million in Q1 2025, with organic growth of 2.2% and a 2.4% contribution from M&A[125]. Profitability - Net income attributable to H.B. Fuller in Q1 2025 was 13.2 million, down 57.4% from 31.0millioninQ12024,withdilutedearningspersharedecreasingfrom31.0 million in Q1 2024, with diluted earnings per share decreasing from 0.55 to 0.24[98][114].Grossprofitmargindecreasedby70basispointsto28.80.24[98][114]. - Gross profit margin decreased by 70 basis points to 28.8% in Q1 2025, primarily due to higher raw material and manufacturing costs[104]. - SG&A expenses increased by 4.8% to 180.6 million in Q1 2025, representing 22.9% of net revenue, up from 21.3% in Q1 2024[105]. - Segment operating income for Engineering Adhesives rose by 8.5% to 28.0million,whilesegmentoperatingmarginimprovedby40basispointsto11.828.0 million, while segment operating margin improved by 40 basis points to 11.8%[124]. - Segment operating income for Building Adhesive Solutions decreased by 8.3% to 6.6 million, with segment operating margin declining by 40 basis points to 3.6%[125]. Cash Flow and Debt - Free cash flow for Q1 2025 was (85.9)million,asignificantdecreasefrom(85.9) million, a significant decrease from 4.1 million in Q1 2024[138]. - Net cash provided by operating activities was (52.9)millioninQ12025,comparedto(52.9) million in Q1 2025, compared to 47.4 million in Q1 2024[140]. - Total cash and cash equivalents as of March 1, 2025, were 105.7million,downfrom105.7 million, down from 165.2 million as of March 2, 2024[130]. - Total long and short-term debt increased to 2,180.0millionasofMarch1,2025,comparedto2,180.0 million as of March 1, 2025, compared to 1,830.8 million as of March 2, 2024, resulting in a total debt to total capital ratio of 55.1%[130]. - Changes in net working capital resulted in a cash use of 27.5millioninQ12025,comparedtoacashsourceof27.5 million in Q1 2025, compared to a cash source of 34.3 million in Q1 2024[141]. Investment and Financing Activities - Net cash used in investing activities was 121.4millioninQ12025,upfrom121.4 million in Q1 2025, up from 42.7 million in Q1 2024, with property, plant, and equipment purchases at 33.0million[143].Thecompanypaid33.0 million[143]. - The company paid 162.0 million in cash for business acquisitions during Q1 2025 and received 75.8millionfromthesaleofNAFlooring[144].Netcashprovidedbyfinancingactivitieswas75.8 million from the sale of NA Flooring[144]. - Net cash provided by financing activities was 111.4 million in Q1 2025, compared to a cash use of 16.9millioninQ12024[145].Borrowingsontherevolvingcreditfacilitytotaled16.9 million in Q1 2024[145]. - Borrowings on the revolving credit facility totaled 526.3 million in Q1 2025, with repayments amounting to 359.5million[145].Cashdividendspaidincreasedto359.5 million[145]. - Cash dividends paid increased to 12.2 million in Q1 2025 from 11.2millioninQ12024,whilecommonstockrepurchasesroseto11.2 million in Q1 2024, while common stock repurchases rose to 44.4 million from 6.2million[145].OtherFinancialMetricsOtherincome,netdecreasedby113.36.2 million[145]. Other Financial Metrics - Other income, net decreased by 113.3% to 1.5 million in Q1 2025, compared to 3.2millioninQ12024[107].Interestexpenseslightlyincreasedto3.2 million in Q1 2024[107]. - Interest expense slightly increased to 32.0 million in Q1 2025 from 31.9millioninQ12024[108].Incomefromequitymethodinvestmentsdecreasedby50.031.9 million in Q1 2024[108]. - Income from equity method investments decreased by 50.0% to 0.5 million in Q1 2025, down from 1.0millioninQ12024[113].Tradereceivablesprovided1.0 million in Q1 2024[113]. - Trade receivables provided 13.9 million in cash in Q1 2025, down from 56.9millioninQ12024,withDaysSalesOutstanding(DSO)increasingto61days[142].Inventoryusagedecreasedto56.9 million in Q1 2024, with Days Sales Outstanding (DSO) increasing to 61 days[142]. - Inventory usage decreased to 27.1 million in Q1 2025 from 50.2millioninQ12024,withinventorydaysonhandat79days[142].Tradepayablesresultedinacashuseof50.2 million in Q1 2024, with inventory days on hand at 79 days[142]. - Trade payables resulted in a cash use of 14.3 million in Q1 2025, compared to a cash source of 27.6millioninQ12024,withDaysPayableOutstandingremainingat73days[142].RestructuringandMarketRisksRestructuringplansareexpectedtoincurcostsofapproximately27.6 million in Q1 2024, with Days Payable Outstanding remaining at 73 days[142]. Restructuring and Market Risks - Restructuring plans are expected to incur costs of approximately 60.0 million to 65.0million,with65.0 million, with 61.7 million already incurred as of March 1, 2025[99]. - The company remains exposed to market risks including interest rates and foreign currency rates, with no material changes reported since November 30, 2024[149].